Health and Fitness Health and Fitness
Wed, October 6, 2010
[ Wed, Oct 06th 2010 ] - Market Wire
Aetna Continues Efforts to Improve Access to Quality Care in the Middle East
[ Wed, Oct 06th 2010 ] - Market Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2010
[ Wed, Oct 06th 2010 ] - Market Wire
Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures
[ Wed, Oct 06th 2010 ] - Market Wire
Levi & Korsinsky, LLP Announces Class Action Laws .. Pharmaceuticals, Inc. and Its Board of Directors
Tue, October 5, 2010
[ Tue, Oct 05th 2010 ] - Market Wire
Medwell Capital announces management change
[ Tue, Oct 05th 2010 ] - Market Wire
Synergetics USA to Webcast Presentation at Craig-Hallum Capital Group 2010 Alpha Select Conference
[ Tue, Oct 05th 2010 ] - Market Wire
VARIAN MEDICAL SYSTEMS AND IMRIS TO CO-DEVELOP RE .. OLUTIONARY NEW MR-GUIDED RADIATION THERAPY SYSTEM
[ Tue, Oct 05th 2010 ] - Market Wire
The Briscoe Law Firm Investigates Johnson & Johns .. for Possible Breaches of Fiduciary Duties by its
[ Tue, Oct 05th 2010 ] - Market Wire
Apricus Bio Closes Securities Offering, Raising over $9.3 Million
[ Tue, Oct 05th 2010 ] - Market Wire
International Stem Cell Corporation and Insight B .. dian Affiliate to Develop Stem Cell-Based Eye Car
[ Tue, Oct 05th 2010 ] - Market Wire
In un importante studio la matrice tissutale rico .. ea" esibisce un elevato tasso di successo nel tra
[ Tue, Oct 05th 2010 ] - Market Wire
La matriz de tejido reconstructivo LifeCella" Str .. ndice de ©xito en el tratamiento de hernias vent
[ Tue, Oct 05th 2010 ] - Market Wire
LifeCella" Stratticea" Rekonstruktive Gewebematri .. ne hohe Erfolgsrate bei der Behandlung von komple
[ Tue, Oct 05th 2010 ] - Market Wire
LifeCell Strattice Reconstructive Tissue Matrix v .. complexe buikbreuken volgens belangrijk onderzoek
[ Tue, Oct 05th 2010 ] - Market Wire
Human Genome Sciences Receives Complete Response .. from FDA on ZALBINa" BLA for Chronic Hepatitis C
[ Tue, Oct 05th 2010 ] - Market Wire
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
[ Tue, Oct 05th 2010 ] - Market Wire
Spectral Molecular Imaging Announces the Appointm .. President for International Business Development
[ Tue, Oct 05th 2010 ] - Market Wire
ImmunoCellular Therapeutics' Clinical Data for ICT-107 To Be Featured at World Stem Cell Summit
[ Tue, Oct 05th 2010 ] - Market Wire
Bond Labs Expands Retail Presence of Resurrectiona" in Minneapolis
[ Tue, Oct 05th 2010 ] - Market Wire
Celgene Prices $1.25 Billion of Senior Unsecured Notes
[ Tue, Oct 05th 2010 ] - Market Wire
Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma
[ Tue, Oct 05th 2010 ] - Market Wire
Philadelphia Eagles' Offensive Lineman Todd Herre .. ical to Endorse New SPO Wellness(TM) Product Line
[ Tue, Oct 05th 2010 ] - Market Wire
Orthovita Receives FDA Clearance for VITOMATRIXa" Bone Graft Substitute in Dental Applications
Mon, October 4, 2010
[ Mon, Oct 04th 2010 ] - Market Wire
The Briscoe Law Firm Investigates Baxter Internat .. eholders for Possible Breaches of Fiduciary Dutie
[ Mon, Oct 04th 2010 ] - Market Wire
Celera Announces Resignation of Chief Financial Officer
[ Mon, Oct 04th 2010 ] - Market Wire
Biogen Idec to Report Third Quarter 2010 Financial Results on October 26, 2010
[ Mon, Oct 04th 2010 ] - Market Wire
Alcon Names New Chief Financial Officer
[ Mon, Oct 04th 2010 ] - Market Wire
Wright Medical Group, Inc. Receives Department of .. Study of OSTEOSET® T Bone Graft Substitute in Co
[ Mon, Oct 04th 2010 ] - Market Wire
NUVO RESEARCH TO PRESENT AT BIOCONTACT QUEBEC 2010 BIOPHARMACEUTICAL CONFERENCE
[ Mon, Oct 04th 2010 ] - Market Wire
Atrium Innovations to Present at Upcoming Canaccord Genuity Healthy Living Conference

Atrium Innovations to Present at Upcoming Canaccord Genuity Healthy Living Conference


Published on 2010-10-04 07:41:23 - Market Wire
  Print publication without navigation


QUEBEC CITY, Oct. 4 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB) today announced that its President and Chief Executive Officer, Mr. Pierre Fitzgibbon, will present a company overview at the upcoming Canaccord Genuity Healthy Living Conference on Wednesday, October 13, 2010 at 10:35 a.m. (ET) at the Intercontinental Hotel in Boston.

About Atrium

Atrium Innovations Inc. is a globally recognized leader in the innovation, formulation, production and commercialization of science-based and professionally endorsed dietary supplements for the health & nutrition industry. The Company focuses primarily on growing segments of the health and nutrition markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America and Europe. Atrium has over 925 employees and operates seven manufacturing facilities. Additional information about Atrium is available on its website at [ www.atrium-innovations.com ].

Contributing Sources